CD8A and neoplasm: These observations confirmed that CD4+ T cells preferentially interact with MHC-II+ antigen-presenting cells at the invasive tumour margin, whereas CD8+ T cells require MHC-I expression on tumour cells to exert their effector functions in vivo.